Another preferred embodiment of the present invention relates to compounds of the formula I, wherein B is a group of the formula 1_ or 8_ and A, ~ \.~ , R 2, R3, Z1, Z2, q, Y1 and Y2 are as defined with respect to formula I, and pharmaceutically acceptable salts thereof.